Bonus Biogroup Ltd. (BBIXF)
OTHER OTC:BBIXF
Total Valuation
Bonus Biogroup has a market cap or net worth of $139.98M. The enterprise value is $459.23M.
Market Cap$139.98M
Enterprise Value$459.23M
Share Statistics
Bonus Biogroup has 1,168,135,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,168,135,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bonus Biogroup’s return on equity (ROE) is 4.32 and return on invested capital (ROIC) is -699.94%.
Return on Equity (ROE)4.32
Return on Assets (ROA)-1.59
Return on Invested Capital (ROIC)-699.94%
Return on Capital Employed (ROCE)-15.64
Revenue Per Employee0.00
Profits Per Employee-499.80K
Employee Count49
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bonus Biogroup is ―. Bonus Biogroup’s PEG ratio is -0.13.
PE Ratio―
PS Ratio0.00
PB Ratio-29.68
Price to Fair Value-29.68
Price to FCF-11.25
Price to Operating Cash Flow-19.66
PEG Ratio-0.13
Income Statement
In the last 12 months, Bonus Biogroup had revenue of 0.00 and earned -24.49M in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit-2.76M
Operating Income-22.64M
Pretax Income-24.49M
Net Income-24.49M
EBITDA-19.88M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -18.30M and capital expenditures -82.00K, giving a free cash flow of -18.38M billion.
Operating Cash Flow-18.30M
Free Cash Flow-18.38M
Free Cash Flow per Share-0.02
Dividends & Yields
Bonus Biogroup pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-53.66
52-Week Price Change225.00%
50-Day Moving Average0.09
200-Day Moving Average0.08
Relative Strength Index (RSI)69.61
Average Volume (3m)475.00
Important Dates
Bonus Biogroup upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Bonus Biogroup as a current ratio of 0.13, with Debt / Equity ratio of -573.31%
Current Ratio0.13
Quick Ratio0.13
Debt to Market Cap0.01
Net Debt to EBITDA-0.44
Interest Coverage Ratio-32.20
Taxes
In the past 12 months, Bonus Biogroup has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bonus Biogroup EV to EBITDA ratio is -8.89, with an EV/FCF ratio of -11.83.
EV to Sales0.00
EV to EBITDA-8.89
EV to Free Cash Flow-11.83
EV to Operating Cash Flow-11.84
Balance Sheet
Bonus Biogroup has $1.20M in cash and marketable securities with $9.60M in debt, giving a net cash position of -$8.41M billion.
Cash & Marketable Securities$1.20M
Total Debt$9.60M
Net Cash-$8.41M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bonus Biogroup is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―